An M, Matsumoto Y, Kishi T, Terakado H, Ikawa M, Hamada E, Watanabe Y, Nakasato S, Murata M, Takaki S, Miura T, Idezuki Y, Kobayashi M
Dept. of Surgery, Miura Hospital.
Gan To Kagaku Ryoho. 1998 Jul;25(9):1330-2.
Epirubicin and 5-FU were administered through an indwelling catheter inserted into the internal mammary artery and/or subclavian artery employing an implantable infusion port system for the treatment of unresectable advanced breast cancer and recurrent breast cancer. Intraarterial infusion chemotherapy proved to be an effective treatment modality for unresectable advanced breast cancer and recurrent breast cancer.
表柔比星和5-氟尿嘧啶通过插入内乳动脉和/或锁骨下动脉的留置导管,采用植入式输注端口系统给药,用于治疗不可切除的晚期乳腺癌和复发性乳腺癌。动脉内灌注化疗被证明是治疗不可切除的晚期乳腺癌和复发性乳腺癌的一种有效治疗方式。